{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:12:44Z","timestamp":1789441964672,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-025-01178-8","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T19:53:06Z","timestamp":1764964386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Design of Experiments and Risk Management-Driven Analytical Platform for Charge Variant Analysis of Therapeutic Antibodies by Imaged Capillary Isoelectric Focusing"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4113-0107","authenticated-orcid":false,"given":"Virginia","family":"Ghizzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6000-5079","authenticated-orcid":false,"given":"Serena","family":"Orlandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7208-4122","authenticated-orcid":false,"given":"Alessandro","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6389-4062","authenticated-orcid":false,"given":"Benedetta","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-5883","authenticated-orcid":false,"given":"Sara","family":"Tengattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1925-7845","authenticated-orcid":false,"given":"Caterina","family":"Temporini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-2248","authenticated-orcid":false,"given":"Roberto","family":"Gotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3035-9076","authenticated-orcid":false,"given":"Gabriella","family":"Massolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-9235","authenticated-orcid":false,"given":"Sandra","family":"Furlanetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1362-2808","authenticated-orcid":false,"given":"Francesca","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"1178_CR1","unstructured":"ICH Harmonised Tripartite Guideline, Final Concept Paper, ICH Q14: Analytical Procedure Development and Revision of Q2(R1) Analytical Validation dated 14 November 2018. 2018. Available at: https:\/\/database.ich.org\/sites\/default\/files\/Q2R2-Q14_EWG_Concept_Paper_1.pdf. Accessed 28 Jul 2025."},{"key":"1178_CR2","unstructured":"ICH Harmonised Tripartite Guideline. Analytical procedure development Q14. 2023. Available at: https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Guideline_2023_1116.pdf. Accessed 28 Jul 2025."},{"key":"1178_CR3","unstructured":"ICH Harmonised Tripartite Guideline. Quality risk management Q9(R1). 2023. Available at: https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q9%28R1%29_Guideline_Step4_2025_0115.pdf. Accessed 28 Jul 2025."},{"key":"1178_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/acs.analchem.4c04521","volume":"97","author":"M Eberle","year":"2025","unstructured":"Eberle M, Wasylenko JT, Kostelac D, Kiehna S, Schellinger A, Zhang Z, et al. A modern framework for analytical procedure development and lifecycle management based on ICH Q14 principles. Anal Chem. 2025;97:12\u201321. https:\/\/doi.org\/10.1021\/acs.analchem.4c04521.","journal-title":"Anal Chem"},{"key":"1178_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jpba.2018.07.050","volume":"161","author":"R Deidda","year":"2018","unstructured":"Deidda R, Orlandini S, Hubert P, Hubert C. Risk-based approach for method development in pharmaceutical quality control context: a critical review. J Pharm Biomed Anal. 2018;161:110\u201321. https:\/\/doi.org\/10.1016\/j.jpba.2018.07.050.","journal-title":"J Pharm Biomed Anal"},{"key":"1178_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113412","volume":"188","author":"J Kopp","year":"2020","unstructured":"Kopp J, Zauner FB, Pell A, Hausjell J, Humer D, Ebner J, et al. Development of a generic reversed-phase liquid chromatography method for protein quantification using analytical quality-by-design principles. J Pharm Biomed Anal. 2020;188:113412. https:\/\/doi.org\/10.1016\/j.jpba.2020.113412.","journal-title":"J Pharm Biomed Anal"},{"key":"1178_CR7","doi-asserted-by":"publisher","first-page":"116220","DOI":"10.1016\/j.jpba.2024.116386","volume":"246","author":"T Cernosek","year":"2024","unstructured":"Cernosek T, Dalphin M, Jain N, Richter N, Beard S, Wang J, et al. Application of Analytical Quality by Design to the development and validation of reduced and non-reduced capillary electrophoresis analytical procedures for mAb purity determination. J Pharm Biomed Anal. 2024;246:116220. https:\/\/doi.org\/10.1016\/j.jpba.2024.116386.","journal-title":"J Pharm Biomed Anal"},{"key":"1178_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2024.124037","volume":"1235","author":"T Cernosek","year":"2024","unstructured":"Cernosek T, Jain N, Dalphin M, Behrens S, Wunderli P. Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments. J Chromatogr B Analyt Technol Biomed Life Sci. 2024;1235:124037. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124037.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1178_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/elps.8110","volume":"18","author":"E vanTricht","year":"2025","unstructured":"vanTricht E, S\u00e4nger-van de Griend CE. A Practical Approach to Implementing ICHQ14: Tools for Analytical Quality by Design in Capillary Electrophoresis Method Development. Electrophoresis. 2025;18:1\u201321. https:\/\/doi.org\/10.1002\/elps.8110.","journal-title":"Electrophoresis"},{"key":"1178_CR10","unstructured":"European Pharmacopoeia. 11th ed. Council of Europe, Strasbourg. Supplement 11.8, General text 2.5.44 \u201cCapillary isoelectric focusing for recombinant therapeutic monoclonal antibodies\u201d in force since 1 July 2025. 2023. Available at https:\/\/pheur.edqm.eu\/app\/11-8\/content\/11-8\/20544E.htm?highlight=on&terms%5B%5D=2.5.44. Accessed 28 Jul 2025."},{"key":"1178_CR11","doi-asserted-by":"publisher","unstructured":"Quinteros DA, Berm\u00fadez JM, Ravetti S, Cid A, Allemandi DA, Palma SD. Therapeutic use of monoclonal antibodies: general aspects and challenges for drug delivery. In: Nanostructures for Drug Delivery 2017;807\u201333. https:\/\/doi.org\/10.1016\/B978-0-323-46143-6.00025-7.","DOI":"10.1016\/B978-0-323-46143-6.00025-7"},{"key":"1178_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nbt1252","volume":"24","author":"G Walsh","year":"2006","unstructured":"Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol. 2006;24:1241\u201352. https:\/\/doi.org\/10.1038\/nbt1252.","journal-title":"Nat Biotechnol"},{"key":"1178_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12033-008-9049-4","volume":"39","author":"N Jenkins","year":"2008","unstructured":"Jenkins N, Murphy L, Tyther R. Post-translational modifications of recombinant proteins: significance for biopharmaceuticals. Mol Biotechnol. 2008;39:113\u20138. https:\/\/doi.org\/10.1007\/s12033-008-9049-4.","journal-title":"Mol Biotechnol"},{"key":"1178_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.biologicals.2016.06.005","volume":"44","author":"N Alt","year":"2016","unstructured":"Alt N, Zhang TY, Motchnik P, Taticek R, Quarmby V, Schlothauer T, et al. Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 2016;44:291\u2013305. https:\/\/doi.org\/10.1016\/j.biologicals.2016.06.005.","journal-title":"Biologicals"},{"key":"1178_CR15","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/elps.201600078","volume":"37","author":"SK Singh","year":"2016","unstructured":"Singh SK, Narula G, Rathore AS. Should charge variants of monoclonal antibody therapeutics be considered critical quality attributes? Electrophoresis. 2016;37:2338\u201346. https:\/\/doi.org\/10.1002\/elps.201600078.","journal-title":"Electrophoresis"},{"key":"1178_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/antib11040073","volume":"11","author":"A Beck","year":"2022","unstructured":"Beck A, Nowak C, Meshulam D, Reynolds K, Chen D, Pacardo DB, et al. Risk-based control strategies of recombinant monoclonal antibody charge variants. Antibodies (Basel). 2022;11:73. https:\/\/doi.org\/10.3390\/antib11040073.","journal-title":"Antibodies (Basel)"},{"key":"1178_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jchromb.2017.02.017","volume":"1048","author":"Y Leblanc","year":"2017","unstructured":"Leblanc Y, Ramon C, Bihoreau N, Chevreux G. Charge variants characterization of a monoclonal antibody by ion exchange chromatography coupled on-line to native mass spectrometry: case study after a long-term storage at +5\u00b0C. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1048:130\u20139. https:\/\/doi.org\/10.1016\/j.jchromb.2017.02.017.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1178_CR18","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1021\/acs.analchem.3c00791","volume":"95","author":"Z Liu","year":"2023","unstructured":"Liu Z, Cao Y, Zhang L, Xu Y, Zhang Z. In-depth characterization of mAb charge variants by on-line multidimensional liquid chromatography-mass spectrometry. Anal Chem. 2023;95:7977\u201384. https:\/\/doi.org\/10.1021\/acs.analchem.3c00791.","journal-title":"Anal Chem"},{"key":"1178_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2019.05.014","volume":"1122","author":"A Lechner","year":"2019","unstructured":"Lechner A, Giorgetti J, Gahoual R, Beck A, Leize-Wagner E, Fran\u00e7ois YN. Insights from capillary electrophoresis approaches for characterization of monoclonal antibodies and antibody drug conjugates in the period 2016\u20132018. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1122:1\u201317. https:\/\/doi.org\/10.1016\/j.jchromb.2019.05.014.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1178_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2025.118212","volume":"187","author":"T Bo","year":"2025","unstructured":"Bo T, Yang F, Yan B, Michels DA, Huang T, Pawliszyn J. Recent developments of imaged capillary isoelectric focusing technology for in-depth biopharmaceutical characterization. Trends Analyt Chem. 2025;187:118212. https:\/\/doi.org\/10.1016\/j.trac.2025.118212.","journal-title":"Trends Analyt Chem"},{"key":"1178_CR21","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1002\/elps.201800079","volume":"39","author":"J Kahle","year":"2018","unstructured":"Kahle J, W\u00e4tzig H. Determination of protein charge variants with (imaged) capillary isoelectric focusing and capillary zone electrophoresis. Electrophoresis. 2018;39:2492\u2013511. https:\/\/doi.org\/10.1002\/elps.201800079.","journal-title":"Electrophoresis"},{"key":"1178_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-0716-1186-9_8","volume":"2261","author":"J Wu","year":"2021","unstructured":"Wu J, McElroy W, Haitjema C, L\u00fcck C, Heger C. Platform Methods to Characterize the Charge Heterogeneity of Three Common Protein Therapeutics by Imaged Capillary Isoelectric Focusing. Methods Mol Biol. 2021;2261:93\u2013103. https:\/\/doi.org\/10.1007\/978-1-0716-1186-9_8.","journal-title":"Methods Mol Biol"},{"key":"1178_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.115178","volume":"224","author":"X Zhang","year":"2023","unstructured":"Zhang X, Kwok T, Zhou M, Du M, Li V, Bo T, et al. Imaged capillary isoelectric focusing (icIEF) tandem high resolution mass spectrometry for charged heterogeneity of protein drugs in biopharmaceutical discovery. J Pharm Biomed Anal. 2023;224:115178. https:\/\/doi.org\/10.1016\/j.jpba.2022.115178.","journal-title":"J Pharm Biomed Anal"},{"key":"1178_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2025.100204","volume":"12","author":"T Kwok","year":"2025","unstructured":"Kwok T, Chan SL, Zhou M, Chen T, Xu N, Li V, et al. An integrated protocol based on workflows of imaged capillary isoelectric focusing (icIEF) for in-depth protein heterogeneous characterization: high-efficient fractionation and online mass spectrometry detection. Green Anal Chem. 2025;12:100204. https:\/\/doi.org\/10.1016\/j.greeac.2025.100204.","journal-title":"Green Anal Chem"},{"key":"1178_CR25","unstructured":"Menneteau T, Butr\u00e9 C, Van Vyncht G, Delobel A, Talbot L, Galaup M, Lebozec K. In-depth characterisation of antibody charge variants by icIEF fractionation coupled to intact mass spectrometry and peptide mapping. Quality Assistance Application Note; 2024. Available at: https:\/\/www.quality-assistance.com\/depth-characterisation-antibody-charge-variants-icief-fractionation-coupled-intact-mass. Accessed 28 Jul 2025."},{"key":"1178_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2022.116567","volume":"150","author":"J Wu","year":"2022","unstructured":"Wu J, McElroy W, Pawliszyn J, Heger CD. Imaged capillary isoelectric focusing: applications in the pharmaceutical industry and recent innovations of the technology. Trends Analyt Chem. 2022;150:116567. https:\/\/doi.org\/10.1016\/j.trac.2022.116567.","journal-title":"Trends Analyt Chem"},{"key":"1178_CR27","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/elps.202100348","volume":"43","author":"S Madren","year":"2022","unstructured":"Madren S, McElroy W, Schultz-Kuszak K, Boumajny B, Shu Y, Sautter S, et al. Global intercompany assessment of ICIEF platform comparability for the characterization of therapeutic proteins. Electrophoresis. 2022;43:1050\u20138. https:\/\/doi.org\/10.1002\/elps.202100348.","journal-title":"Electrophoresis"},{"key":"1178_CR28","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1039\/D0AY00823K","volume":"12","author":"X Li","year":"2020","unstructured":"Li X, Shi X, Qin X, Yu L, Zhou Y, Rao C. Interlaboratory method validation of imaged capillary isoelectric focusing methodology for analysis of recombinant human erythropoietin. Anal Methods. 2020;12:3836\u201343. https:\/\/doi.org\/10.1039\/D0AY00823K.","journal-title":"Anal Methods"},{"key":"1178_CR29","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1002\/jssc.201200633","volume":"35","author":"O Salas-Solano","year":"2012","unstructured":"Salas-Solano O, Kennel B, Park SS, Roby K, Sosic Z, Boumajny B, et al. Robustness of iCIEF methodology for the analysis of monoclonal antibodies: an interlaboratory study. J Sep Sci. 2012;35:3124\u20139. https:\/\/doi.org\/10.1002\/jssc.201200633.","journal-title":"J Sep Sci"},{"key":"1178_CR30","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/elps.201800118","volume":"39","author":"G Wu","year":"2018","unstructured":"Wu G, Yu C, Wang W, Wang L. Interlaboratory method validation of icIEF methodology for analysis of monoclonal antibodies. Electrophoresis. 2018;39:2091\u20138. https:\/\/doi.org\/10.1002\/elps.201800118.","journal-title":"Electrophoresis"},{"key":"1178_CR31","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/elps.202400066","volume":"45","author":"G Wu","year":"2024","unstructured":"Wu G, Du J, Xu G, Li M, Yu C. Possibility of using the imaged capillary isoelectric method as a multi-attribute method for bispecific antibodies. Electrophoresis. 2024;45:1665\u201372. https:\/\/doi.org\/10.1002\/elps.202400066.","journal-title":"Electrophoresis"},{"key":"1178_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2024.2313737","volume":"16","author":"A Ascione","year":"2024","unstructured":"Ascione A, Belfiore M, Vesterinen J, Buda M, Holtkamp W, Luciani F. Charge heterogeneity of therapeutic monoclonal antibodies by different cIEF systems: views on the current situation. MAbs. 2024;16:2313737. https:\/\/doi.org\/10.1080\/19420862.2024.2313737.","journal-title":"MAbs"},{"key":"1178_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107297","volume":"214","author":"V Ghizzani","year":"2025","unstructured":"Ghizzani V, Gonnella F, Gaggioli A, Carocci A, Luciani F, Ascione A. Development and validation of an optimized and horizontal imaged capillary isoelectric focusing method for mAbs charge heterogeneity analysis. EJPS. 2025;214:107297. https:\/\/doi.org\/10.1016\/j.ejps.2025.107297.","journal-title":"EJPS"},{"key":"1178_CR34","unstructured":"Ph. Eur. Commission adopts first \u201chorizontal standard\u201d for monoclonal antibodies. EDQM Newsroom. Available at: https:\/\/www.edqm.eu\/en\/-\/ph.-eur.-commission-adopts-first-horizontal-standard-for-monoclonal-antibodies. Accessed 28 Jul 2025."},{"key":"1178_CR35","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.4161\/mabs.32221","volume":"6","author":"SK Jung","year":"2014","unstructured":"Jung SK, Lee KH, Jeon JW, Lee JW, Kwon BO, Kim YJ, et al. Physicochemical characterization of Remsima. MAbs. 2014;6:1163\u201377. https:\/\/doi.org\/10.4161\/mabs.32221.","journal-title":"MAbs"},{"key":"1178_CR36","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1248\/bpb.b18-00491","volume":"41","author":"M Tsuda","year":"2018","unstructured":"Tsuda M, Otani Y, Yonezawa A, Masui S, Ikemi Y, Denda M, et al. Analysis of glycoforms and amino acids in Infliximab and a biosimilar product using new method with LC\/TOF-MS. Biol Pharm Bull. 2018;41:1716\u201321. https:\/\/doi.org\/10.1248\/bpb.b18-00491.","journal-title":"Biol Pharm Bull"},{"key":"1178_CR37","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1021\/acs.analchem.6b04436","volume":"89","author":"K Pisupati","year":"2017","unstructured":"Pisupati K, Tian Y, Okbazghi S, Benet A, Ackermann R, Ford M, et al. A multidimensional analytical comparison of Remicade and the biosimilar Remsima. Anal Chem. 2017;89:4838\u201346. https:\/\/doi.org\/10.1021\/acs.analchem.6b04436.","journal-title":"Anal Chem"},{"key":"1178_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/19420862.2016.1264550","volume":"9","author":"J Hong","year":"2017","unstructured":"Hong J, Lee Y, Lee C, Eo S, Kim S, Lee N, et al. Physicochemical and biological characterization of SB2, a biosimilar of Remicade\u00ae (infliximab). MAbs. 2017;9:365\u201383. https:\/\/doi.org\/10.1080\/19420862.2016.1264550.","journal-title":"MAbs"},{"key":"1178_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jchromb.2017.09.033","volume":"1065","author":"A Goyon","year":"2017","unstructured":"Goyon A, Excoffier M, Janin-Bussat MC, Bobaly B, Fekete S, Guillarme D, et al. Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1065:119\u201328. https:\/\/doi.org\/10.1016\/j.jchromb.2017.09.033.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1178_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79108-5","volume":"14","author":"M Belfiore","year":"2024","unstructured":"Belfiore M, Ascione A, Ghizzani V, Di Meo S, Luciani F. A new paradigm for optimized experimental design in cIEF platforms aimed at an accurate robust and reliable mAbs charge-variant assessment. Sci Rep. 2024;14:28087. https:\/\/doi.org\/10.1038\/s41598-024-79108-5.","journal-title":"Sci Rep"},{"key":"1178_CR41","volume-title":"Design of Experiments \u2013 Principles and Applications","author":"L Eriksson","year":"2008","unstructured":"Eriksson L, Johansson E, Kettaneh-Wold N, Wikstr\u00f6m C, Wold S. Design of Experiments \u2013 Principles and Applications. Ume\u00e5, Sweden: MKS Umetrics AB; 2008."},{"key":"1178_CR42","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1021\/acs.analchem.3c03708","volume":"96","author":"PJ Borman","year":"2024","unstructured":"Borman PJ, Guiraldelli AM, Weitzel J, Thompson S, Ermer J, Roussel JM, et al. Ongoing analytical procedure performance verification using a risk-based approach to determine performance monitoring requirements. Anal Chem. 2024;96:966\u201379. https:\/\/doi.org\/10.1021\/acs.analchem.3c03708.","journal-title":"Anal Chem"},{"key":"1178_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.chemolab.2005.04.010","volume":"79","author":"MA Herrador","year":"2005","unstructured":"Herrador MA, Asuero AG, Gonzalez AG. Estimation of the uncertainty of indirect measurements from the propagation of distributions by using the Monte-Carlo method: an overview. Chemom Intell Lab Syst. 2005;79:115\u201322. https:\/\/doi.org\/10.1016\/j.chemolab.2005.04.010.","journal-title":"Chemom Intell Lab Syst"},{"key":"1178_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2025.1536222","volume":"13","author":"V Ghizzani","year":"2025","unstructured":"Ghizzani V, Ascione A, Gonnella F, Massolini G, Luciani F. Exploring imaged capillary isoelectric focusing parameters for enhanced charge variants quality control. Front Chem. 2025;13:1536222. https:\/\/doi.org\/10.3389\/fchem.2025.1536222.","journal-title":"Front Chem"},{"key":"1178_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1021\/acs.analchem.1c03854","volume":"94","author":"PJ Borman","year":"2022","unstructured":"Borman PJ, Campa C, Delpierre G, Hook E, Jackson P, Kelley W, et al. Selection of analytical technology and development of analytical procedures using the analytical target profile. Anal Chem. 2022;94:559\u201370. https:\/\/doi.org\/10.1021\/acs.analchem.1c03854.","journal-title":"Anal Chem"},{"key":"1178_CR46","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/elps.202200170","volume":"44","author":"J Schlecht","year":"2023","unstructured":"Schlecht J, Moritz B, Kiessig S, Neus\u00fc\u00df C. Characterization of therapeutic mAb charge heterogeneity by iCIEF coupled to mass spectrometry (iCIEF-MS). Electrophoresis. 2023;44:540\u20138. https:\/\/doi.org\/10.1002\/elps.202200170.","journal-title":"Electrophoresis"},{"key":"1178_CR47","doi-asserted-by":"publisher","first-page":"115997","DOI":"10.1016\/j.jpba.2024.115997","volume":"241","author":"L Nompari","year":"2024","unstructured":"Nompari L, Orlandini S, Pasquini B, Fontana L, Rovini M, Masi F, et al. Optimization of hydrolysis conditions of amino acid analysis for UHPLC-UV antigens content determination: Bexsero vaccine a case study. J Pharm Biomed Anal. 2024;241:115997. https:\/\/doi.org\/10.1016\/j.jpba.2024.115997.","journal-title":"J Pharm Biomed Anal"},{"key":"1178_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.343176","volume":"1328","author":"C Leng","year":"2024","unstructured":"Leng C, Sun S, Lin W, Pavon JA, Gennaro L, Gunawan RC, et al. Imaged capillary isoelectric focusing method development for charge variants of high DAR ADCs. Anal Chim Acta. 2024;1328:343176. https:\/\/doi.org\/10.1016\/j.aca.2024.343176.","journal-title":"Anal Chim Acta"},{"key":"1178_CR49","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00216-017-0816-6","volume":"410","author":"A Turner","year":"2018","unstructured":"Turner A, Schiel JE. Qualification of NISTmAb charge heterogeneity control assays. Anal Bioanal Chem. 2018;410:2079\u201393. https:\/\/doi.org\/10.1007\/s00216-017-0816-6.","journal-title":"Anal Bioanal Chem"},{"key":"1178_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.chroma.2013.08.021","volume":"1309","author":"M Kinoshita","year":"2013","unstructured":"Kinoshita M, Nakatsuji Y, Suzuki S, Hayakawa T, Kakehi K. Quality assurance of monoclonal antibody pharmaceuticals based on their charge variants using microchip isoelectric focusing method. J Chromatogr A. 2013;1309:76\u201383. https:\/\/doi.org\/10.1016\/j.chroma.2013.08.021.","journal-title":"J Chromatogr A"},{"key":"1178_CR51","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1002\/elps.200800690","volume":"30","author":"S Mack","year":"2009","unstructured":"Mack S, Cruzado-Park I, Chapman J, Ratnayake C, Vigh G. A systematic study in CIEF: defining and optimizing experimental parameters critical to method reproducibility and robustness. Electrophoresis. 2009;30:4049\u201358. https:\/\/doi.org\/10.1002\/elps.200800690.","journal-title":"Electrophoresis"},{"key":"1178_CR52","doi-asserted-by":"publisher","first-page":"124633","DOI":"10.1016\/j.talanta.2023.124633","volume":"260","author":"C Tardif","year":"2023","unstructured":"Tardif C, Jaccoulet E, Bellec JF, Surroca Y, Talbot L, Taverna M, et al. Imaged capillary isoelectric focusing associated with multivariate analysis: A powerful tool for quality control of therapeutic monoclonal antibodies. Talanta. 2023;260:124633. https:\/\/doi.org\/10.1016\/j.talanta.2023.124633.","journal-title":"Talanta"},{"key":"1178_CR53","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1021\/ac3008847","volume":"84","author":"DA Michels","year":"2012","unstructured":"Michels DA, Tu AW, McElroy W, Voehringer D, Salas-Solano O. Charge heterogeneity of monoclonal antibodies by multiplexed imaged capillary isoelectric focusing immunoassay with chemiluminescence detection. Anal Chem. 2012;84:5380\u20136. https:\/\/doi.org\/10.1021\/ac3008847.","journal-title":"Anal Chem"},{"key":"1178_CR54","doi-asserted-by":"publisher","DOI":"10.1201\/9780203508688","volume-title":"Pharmaceutical experimental design","author":"GA Lewis","year":"1999","unstructured":"Lewis GA, Mathieu D, Phan-Tan-Luu R. Pharmaceutical experimental design. New York: Marcel Dekker; 1999. https:\/\/doi.org\/10.1201\/9780203508688."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01178-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:20:18Z","timestamp":1770826818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01178-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01178-8","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"27"}}